DNL343
- Generic Name
- DNL343
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 2278265-85-1
- Unique Ingredient Identifier
- -
- Background
DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343).
- Associated Conditions
- -
- Associated Therapies
- -
HEALEY ALS Platform Trial - Master Protocol
Phase 2
Active, not recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Merit E. Cudkowicz, MD
- Target Recruit Count
- 1500
- Registration Number
- NCT04297683
- Locations
- 🇺🇸
Neurology Associates, P.C./Somnos Clinical Research, Lincoln, Nebraska, United States
🇺🇸Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath